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ABSTRACT 
Aim: Psychiatric disorders are relatively frequent comorbidities in epilepsy and they have an impact 
on morbidity, mortality and quality of life. This is a report from the Task Force on Education of the 
ILAE Commission on Neuropsychiatry based on a survey about educational needs of epileptologists 
regarding management of the psychiatric comorbidities of epilepsy. 
Methods: The Task Force designed a quantitative questionnaire to survey the self-perceived 
confidence of child and adult epileptologists and psychiatrists in managing major psychiatric 
comorbidities of epilepsy to identify (1) critical areas of improvement from a list of skills that are 
usually considered necessary for effective management of these conditions, and (2) the preferred 
educational format for improving these skills. 
Results: A total of 211 respondents from 35 different countries participated in the survey.  
Confidence and usefulness scores suggest that responders would most value education and training 
in the management of specific clinical scenarios. Child neurologists identified major Axis I disorders 
like mood and anxiety disorders, while adult neurologists identified attention deficit hyperactivity 
disorder, intellectual disabilities and autistic spectrum disorder as key areas. Both adult and child 
neurologists identified screening skills as the priority. Psychiatrists mainly valued specific training in 
the management of psychiatric complications of epilepsy surgery or psychiatric adverse events of 
antiepileptic drugs. Sessions during congresses and face-to-face meetings represent the preferred 
educational format, while e-learning modules and review papers were chosen by a minority of 
respondents. 
Conclusions: Results of this survey identify key areas for improvement in managing the psychiatric 
comorbidities of epilepsy and suggest specific strategies to develop better training for clinicians 
involved in epilepsy care. 
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INTRODUCTION 
Epilepsy is now recognized as a disorder of the brain characterized not only by an enduring 
predisposition to generate epileptic seizures, but explicitly also by the neurobiological, cognitive, 
psychological, and social comorbidities of this condition 1. Whilst seizure freedom should represent 
the ultimate goal when possible, it is now becoming evident that numerous factors determine the 
quality of life (QoL) of people with epilepsy, with comorbid depression or the adverse effects of 
medications often constituting stronger predictors of poorer QoL than seizure frequency itself 2. 
Even in those in whom remission is achievable, QoL remains poor if psychiatric comorbidities are 
untreated. Successful integration of people with epilepsy into society is another important goal of 
epilepsy care. Educational level, intellectual ability, psychological stability, family and social support 
and employment opportunities, as well as the ability to overcome stigma, transportation and 
mobility issues are important determinants of successful integration 3. The combination of these 
factors influences the life of people with epilepsy and what they consider meaningful 4. 
A lifetime history of psychiatric disorders can be identified in one in three people with epilepsy 5. 
Mood and anxiety disorders are the most frequently reported 6 for both biological and psychosocial 
reasons. In May 2015, the World Health Assembly approved the WHO Resolution on the Global 
Burden of Epilepsy which provides a powerful tool for engaging national governments in (1) 
implementing effective actions to improve medical and social services for people with epilepsy, (2) 
promoting public awareness about epilepsy, and (3) allocating resources to epilepsy research 7. This 
provides a wonderful opportunity to improve epilepsy care and address the global burden of 
epilepsy so that people with epilepsy can receive timely treatment and benefit from educational and 
occupational opportunities, free from stigma and discrimination. It is, therefore, evident that 
epileptologists need to develop multiple clinical skills and be able to organise care plans involving a 
range of experts and health care professionals in order to address the multiple needs of people with 
epilepsy. 
In 2004, Gilliam et al. reported that only 7% of U.S. neurologists routinely screen epilepsy patients 
for depression in their outpatient clinics 8. Since then, the International League Against Epilepsy 
(ILAE) has developed a number of documents and initiatives in order to increase the awareness of 
epileptologists of the importance of identifying and managing psychiatric problems in epilepsy and 
to provide training and clinical instruments to accomplish this goal. Over time, the ILAE Commissions 
on Neuropsychiatry have developed consensus guidance documents 9, supported the dissemination 
of validated screening instruments for depression like the Neurological Disorders Depression 
Inventory for Epilepsy (NDDIE) 10–15 and, in conjunction with the Virtual Epilepsy Academy (VIREPA), 
offered the on-line course on “Neuropsychiatric aspects of epilepsy” that has been run twice. 
The Task Force on Education of the ILAE Commission on Neuropsychiatry was appointed to 
formulate proposals to address the educational needs of epileptologists about the psychiatric 
comorbidities of epilepsy. This Task Force report is based on the results of a purpose-developed 
survey circulated among epileptologists and other healthcare professionals working with people 
with epilepsy. 
 
METHODS 
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The Task Force on Education of the ILAE Commission on Neuropsychiatry designed a 
quantitative questionnaire to survey the educational needs of epileptologists about managing the 
major psychiatric comorbidities of epilepsy. First, respondents were asked to provide demographic 
information including gender, age and job role. Second, respondents were asked questions about 
their routine practice (i.e. whether they routinely screen for psychiatric comorbidities; reluctance 
about prescribing psychotropic drugs in patients with epilepsy; whether psychiatrists or clinical 
psychologists are available in their treatment setting). Respondents were then asked to rate their 
knowledge/confidence in managing the major psychiatric comorbidities of epilepsy using a 5-point 
Likert-type scale (1=very good, 5=very poor), and to assess the importance of a list of skills that are 
usually considered necessary for effective management of psychiatric comorbidities (i.e. how to 
screen, how to diagnose, how to treat, how to use behavioural interventions, how to deal with 
specific situations such as post-surgical complications or psychiatric adverse events of antiepileptic 
drugs). Finally, the questionnaire asked respondents about their preferred educational format for 
improving their clinical skills (i.e. books/textbooks; review papers/peer review material; face-to-face 
meetings like congresses or symposia; e-learning modules). The questionnaire remained online for 8 
months between October 2015 and May 2016. It was freely available and easily accessible. The 
survey was circulated via the ILAE Regional Chairs, who were asked to send the questionnaire to 
individual ILAE Chapters for distribution. Completion of the questionnaire was entirely anonymous. 
 
RESULTS 
A total of 211 respondents from 35 different countries participated in the survey (Table 1). 
Demographic data are presented in Table 2. The majority of respondents comprise adult 
neurologists/epileptologists, 14.7% are child neurologists/epileptologists, 22.4% 
psychiatrists/neuropsychiatrists, and 5.7% are other healthcare professionals especially epilepsy 
nurses and some neuropsychologists. In almost 40% of cases neither psychiatrists nor clinical 
psychologists form part of the epilepsy team, while one third of respondents work in tertiary 
epilepsy centres with easy access to both. About 50% of respondents stated that they routinely 
screen for psychiatric comorbidities and feel at ease with the prescription of psychotropic 
medications (e.g. antidepressants or antipsychotics) but 1 out of 4 remain reluctant to use these 
medications in patients with epilepsy (Table 2). 
In general terms, management of psychoses, attention deficit hyperactivity disorder (ADHD), 
psychiatric complications of epilepsy surgery and autistic spectrum disorder (ASD) are perceived as 
critical by a large number of clinicians, with almost 1 out of 2 rating individual knowledge/confidence 
as ‘poor’ or ‘very poor’ (Figure 1A).  However, looking at individual group ratings, adult neurologists, 
child neurologists, and psychiatrists show some clear differences (Figure 1B, 1C, 1D). Child 
neurologists mainly perceive Axis I disorders as critical, such as mood and anxiety disorders and 
psychoses, with more than 50% rating their knowledge/confidence as ‘poor’ or ‘very poor’, followed 
by complications of epilepsy surgery (Figure 1B). Conversely, more than 60% of adult neurologists 
feel that their knowledge about ADHD and ASD is poor or very poor, and 1 out 3 rated their 
competence in managing intellectual disabilities and psychiatric complications of epilepsy surgery as 
‘poor’ or ‘very poor’ (Figure 1C). Among psychiatrists, psychiatric complications of epilepsy surgery 
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constitutes the only area rated as ‘poor’ or ‘very poor’ in terms of knowledge/confidence, and by 
only 1 of 5 clinicians (Figure 1D). 
Regarding specific skills rated as the most important by respondents (Figure 2), both adult 
and child neurologists identified screening for major psychiatric comorbidities in outpatient clinics as 
the priority (40% of child neurologists and one third of adult neurologists). Diagnostic issues and 
developing clinical skills for specific situations like psychiatric complications of epilepsy surgery are 
considered a priority by one third of psychiatrists. 
Data relating to the preferred educational format indicate that the majority of respondents 
consider congresses (plenary sessions or symposia) to be most valuable (Figure 3). More than half of  
adult epileptologists and one third of child neurologists and psychiatrists have chosen this as the 
preferred format. 
 
DISCUSSION 
This survey identified key areas of improvement in terms of knowledge and development of 
specific skills for epileptologists regarding management of the psychiatric comorbidities of epilepsy. 
For the first time, psychiatrists were involved in the process and it was possible to identify specific 
needs for adult and child neurologists treating patients with epilepsy. 
Epileptologists are keen to improve their clinical skills and screening during routine clinical 
practice seems to be the priority. Most adult neurologists feel inadequate or not skilled enough 
when dealing with patients with epilepsy and ASD, ADHD or intellectual disabilities in general. Child 
neurologists are historically better trained in these conditions and thus, usually more adept in their 
management. A prospective community-based study in children and adolescents with active epilepsy 
showed that up to 40% of patients have intellectual disabilities (IDs), one third have ADHD, and 
around 20% have ASD 16. In addition, a community-based survey of more than 1000 adults with 
epilepsy reported that ADHD-like symptoms are present in 1 out of 5 patients and are associated 
with depression, anxiety, drug-resistance and poor quality of life 17. It is clear that adult neurologists 
need to be trained in these specific areas in order to maintain good clinical skills in the management 
of complex patients with epilepsy and IDs. The development of Transition Clinics dedicated to 
transition from paediatric to adult epilepsy service may also favour this process. 
Child neurologists identified screening and managing Axis I disorders as the most critical area 
for their clinical skill development. Mood and anxiety disorders in children are still underestimated 
and poorly recognised 18. This is often due to the atypical phenomenology of depression and anxiety 
in children as compared to adults. It is estimated that up to 50% of adult patients with a mood or 
anxiety disorder (not restricted to persons with epilepsy) had an anxiety disorder during childhood 
19, making routine screening crucial for the development of preventative strategies. This is further 
supported by the American Academy of Child and Adolescent Psychiatry that recommends that 
children and adolescents should be routinely screened for symptoms of anxiety 20. In children, the 
rate of self-reported as compared to parent-reported anxiety is higher, suggesting that it is 
important to rely on children’s self-assessment wherever possible but also to develop specific 
guidelines of treatment in order not to overmedicate children with non-specific symptoms. 
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Finally, this report identified congresses as the preferred educational format of the majority 
of respondents. More than half the adult neurologists and about one third of child neurologists and 
psychiatrists chose this format. Review papers and e-learning modules were chosen by a minority (1 
out of 3). This may be explained by the opportunity to discuss personal cases, ask specific questions 
or discuss specific clinical scenarios with colleagues. 
The results of this survey highlight a number of limitations. First, the limited number of 
respondents reflects the still limited interest of epileptologists in the psychiatric comorbidities of 
epilepsy and thus, these results may be representative of a small subgroup of clinicians who are 
already interested in this subject. This is further suggested by the high rate of clinicians stating that 
they routinely screen for psychiatric disorders in clinic, namely more than half. Since the initial 
report of Gilliam et al. 8, showing that only 7% of neurologists routinely screen for depression, the 
ILAE has been strenuously working on a number of educational initiatives. These include two series 
of the VIREPA course on the psychiatric aspects of epilepsy, the dissemination of easy to use 
screening instruments for epileptologists (i.e. the NDDIE), the Latin American Summer School for 
Epilepsy dedicated one edition just to comorbidities. However, relying only on the results of this 
survey to state that now half of neurologists screen for psychiatric comorbidities is probably overly 
optimistic, although it is definitely encouraging. 
Second, the majority of respondents are located in Europe, North America and Australia. 
Although this may be due to language barriers, it is also representative of the still low interest of 
clinicians in other continents about the psychiatric comorbidities of epilepsy. Epilepsy is still a highly 
stigmatised condition, and stigma greatly affects the QoL of people with epilepsy, leading to 
increased anxiety and depression and poor adherence to medication 21. Unfortunately, even 
currently, stigma is present in both high-income and resource-poor countries 22.  Stigma is not only 
responsible for poor QoL but also seems to play a role in mood and anxiety problems in both people 
with epilepsy and their caregivers. Perceived stigma is also responsible for increased rates of 
aggressive behaviour associated with depression and anxiety 23. In low and middle income countries, 
20% of mothers of children with epilepsy feel stigmatized because of their child's neurological 
condition 24 and the caregiver's perception of burden, together with the level of family function, are 
indirectly correlated with depressive symptoms in people with epilepsy via the mediating effect of 
caregiver depression 25. It seems evident, therefore, that one of the future missions of the ILAE 
Commission of Neuropsychiatry will be to increase the awareness of clinicians in low income 
countries of the psychiatric comorbidities of epilepsy, and to explore the consequences of this 
double stigma. 
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Table 1. List of countries that participated in the survey (in alphabetical order). 
Albania 
Argentina 
Australia 
Azerbaijan 
Belgium 
Brazil 
Bulgaria 
Canada 
Denmark 
France 
Georgia 
Germany 
Greece 
Italy 
Japan 
Lithuania 
Mexico 
Montenegro 
New Zealand 
Norway 
Poland 
Republic of Korea 
Russia 
Serbia 
Slovenia 
South Africa 
Spain 
Sweden 
Switzerland 
Thailand 
The former Yugoslav Republic of Macedonia 
Turkey 
Ukraine 
United Kingdom of Great Britain and Northern Ireland 
United States of America 
Zimbabwe 
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Table 2. Profile of respondents. 
 N = 211 
Gender 
Male 
Female 
 
52.4% 
47.6% 
Age 
25-34 
35-44 
45-54 
55-64 
65-74 
>75 
 
10.5% 
24.4% 
34.9% 
20.6% 
9.1% 
0.5% 
Clinical role 
Adult neurologist/Epileptologist 
Child neurologist/Epileptologist 
Psychiatrist 
Child psychiatrist 
Neuropsychiatrist 
Others (i.e. neuropsychologist, epilepsy nurse, mental health nurse, 
neuropathologist) 
 
51% 
14.7% 
16.7% 
6.2% 
5.7% 
5.7% 
Is there a psychiatrist or a psychologist dedicated to patients with epilepsy in 
your centre? 
Yes both 
Only a psychologist 
Only a psychiatrist 
None of them 
 
 
33.8% 
11.4% 
15.7% 
39.1% 
Do you routinely screen for psychiatric problems during your epilepsy clinic? 
Yes (Adult neurologist)  
Yes (Child neurologists) 
 
56.6% 
54.8% 
Are you reluctant about prescribing antidepressants/antipsychotics in 
patients with epilepsy? 
Yes always 
Only for antidepressants 
Only for antipsychotics 
I have no problems 
 
 
25.5% 
4.8% 
19.7% 
50.0% 
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Figure legends. 
Figure 1. Self-perceived knowledge and level of confidence in managing psychiatric comorbidities 
of epilepsy in the total sample (A), among child neurologists (B), adult neurologists (C) and 
psychiatrists/neuropsychiatrists (D). 
A. 
 
B. 
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C. 
 
D. 
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Figure 2. Clinical skills perceived as most important in managing the psychiatric comorbidities of 
epilepsy. 
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Figure 3. Educational formats perceived as the best way to improve knowledge and confidence in 
managing the psychiatric comorbidities of epilepsy. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
